Beta glucan application in preparing human dendritic cell tumor vaccine

Beta glucan application in preparing human dendritic cell tumor vaccine

  • CN 102,600,467 B
  • Filed: 03/29/2012
  • Issued: 06/01/2016
  • Est. Priority Date: 03/29/2012
  • Status: Active Grant
First Claim
Patent Images

1. the beta glucan application in preparing human dendritic cell tumor vaccine being monomer with structural formula shown in Fig. 1;

  • Structural formula shown in described Fig. 1 is as follows;

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×